blfs_8k.htm
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

____________________________________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

October 20, 2011
Date of report (Date of earliest event reported)
____________________________________

BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
 
Delaware   0-18710   94-3076866
(State or Other Jurisdiction of Incorporation)   (Commission File No.)    (IRS Employer Identification No.)
                                                                                                                                                                                                                                   
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)

(425) 402-1400
(Registrant’s telephone number, including area code)

____________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
ITEM 7.01  Regulation FD Disclosure

On October 20, 2011, the Company made available a corporate investor presentation on its website at www.biolifesolutions.com.  The presentation will be used during upcoming discussions with customers and investors. The presentation is furnished and attached as Exhibit 99.1 and incorporated by reference in this Item 7.01.

ITEM 9.01.  Financial Statements and Exhibits.

(a)          Exhibits

99.1   Corporate presentation, dated October 20, 2011, by BioLife Solutions, Inc. (furnished under Item 7.01 of Form 8-K).
 
 
 
 
2
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BIOLIFE SOLUTIONS, INC.
  
       
Date:  October 20, 2011
By:
/s/Daphne Taylor  
    Daphne Taylor  
    Chief Financial Officer  
       
 
 
 
3